Risk of RSV-related hospitalization is associated with gestational age in preterm (born at 29–34 wGA) infants without outpatient palivizumab administration-Reference-Cited by-同舟云学术

Risk of RSV-related hospitalization is associated with gestational age in preterm (born at 29–34 wGA) infants without outpatient palivizumab administration

Published:2023-08 Issue:2 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Packnett Elizabeth R.¹^ORCID,Winer Isabelle H.¹,Oladapo Abiola²,Wojdyla Matthew²

Affiliation:

1. Real World Data Research & Analytics, Merative, Ann Arbor, MI, USA

2. Medical Affairs, Sobi, Waltham, MA, USA

Funder

Sobi

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2023.2252289

Reference31 articles.

1. Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease

2. The Burgeoning Burden of Respiratory Syncytial Virus Among Children

3. The Burden of Respiratory Syncytial Virus Infection in Young Children

4. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000

5. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An evaluation of 2015–2019 United States respiratory syncytial virus hospitalizations as a framework to develop potential strategies for the preventiosn of the hospital burden among infants;eClinicalMedicine;2024-09

2. Research Progress in Prevention and Treatment of Respiratory Syncytial Virus Infection in Infants;Advances in Clinical Medicine;2023